Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Dow
McKinsey
McKesson
Harvard Business School
Merck
Mallinckrodt

Last Updated: September 27, 2022

Patent: 10,112,941


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


Summary for Patent: 10,112,941
Title:Tricyclic compounds as anticancer agents
Abstract: The present invention is directed to tricyclic compounds, pharmaceutically acceptable compositions comprising compounds of the invention and methods of using said compositions in the treatment of various disorders.
Inventor(s): Norris; Derek J. (Pennington, NJ), Delucca; George V. (Pennington, NJ), Gavai; Ashvinikumar V. (Princeton Junction, NJ), Lee; Francis Y. (Yardley, PA), Tokarski; John S. (Princeton, NJ)
Assignee: Bristol-Myers Squibb Company (Princeton, NJ)
Application Number:15/661,373
Patent Claims:see list of patent claims

Details for Patent 10,112,941

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Bristol-myers Squibb Company OPDIVO nivolumab Injection 125554 12/22/2014 See Plans and Pricing 2033-12-24
Bristol-myers Squibb Company OPDIVO nivolumab Injection 125554 10/04/2017 See Plans and Pricing 2033-12-24
Bristol-myers Squibb Company OPDIVO nivolumab Injection 125554 08/27/2021 See Plans and Pricing 2033-12-24
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
McKesson
Colorcon
Dow
Mallinckrodt
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.